Exchange: NSE·Updated 04:00 PM GMT+5:30
News
all
press releases
Sun Pharma Considers Debt Swap, Bonds for Mega USD 12 Billion Organon Acquisition: Report
… proposed merger , they added. Separately, the company is planning to raise as much as … would rank among the largest outbound acquisitions by an Indian drugmaker and … multiple aspects and milestones of the acquisition including finalizing the long-term capital …
cityfalcon.com
More News
Indian industry led by pharma to invest $20.5 billion in the US
Includes $1.1 bn announced at SelectUSA 2026 and Sun Pharma’s $11.75 billionn Organon acquisition
cityfalcon.com
Organon Deal: Sun Pharma's Biggest Bet Faces A Growth Test
… of the country’s largest pharmaceutical (pharma ) company, Sun Pharmaceutical Industries, rose 7 per … the largest overseas acquisition by an Indian pharma company. The sharp gains in the stock … of a business spun off from Merck in 2021 offers Sun entry …
cityfalcon.com
India's Sun Pharma buys Organon for $12B boosting specialty portfolio
Sun Pharma , India's biggest … 's lineup, including drugs for breast cancer and women …
cityfalcon.com
THE PHARMA FRONTIER: Sun Pharma’s Global Leap Amidst Market Resilience
Today, Monday, May 4, 2026, the Indian pharmaceutical landscape has reached a historic milestone. While the broader markets showed… Continue reading on Medium »
cityfalcon.com
OGN Stock Set For Blastoff? Sun Pharma Offers 24% Premium In All-Cash Buyout Deal
OGN stock is on track for a record monthly gain, rising 88% in April, including a 31% surge on Friday, its strongest session ever.
Stocktwits
Why Is OGN Stock Rising In Pre-Market Today?
India’s Sun Pharmaceutical Industries submitted a binding $13 billion offer to acquire Organon, according to an Economic Times article on Friday.
Stocktwits
OGN Stock Surges 20% Pre-Market, On Track To Break 200-DMA – Why This Buyout Report Has Caught Investor Attention
A report stated that Indian pharmaceutical giant Sun Pharma is expected to submit a $12 billion binding offer for the company.
Stocktwits
Breakout Buys: Tata Steel, BSE, Vedanta And Sun Pharma Poised For Upside
These four stocks have shown strong technical setups backed by heavy volumes.
Stocktwits
Will Trump’s 100% Tariffs Derail Indian Pharma Stocks? SEBI Analyst Flags Key Levels For Traders
The new U.S. duty has already triggered a slide in major Asian pharma names, raising concerns about how Indian peers will react in the coming weeks.
Stocktwits

Advertisement|Remove ads.